Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27154,124,1.47 [0.96-2.26],0.0786359354601386
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27922,206,1.05 [0.76-1.47],0.7583195295879677
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27636,1375,0.80 [0.71-0.91],0.0007366944132336
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Candidiasis,27949,481,0.74 [0.59-0.91],0.0044791696772994
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27079,3587,0.83 [0.77-0.90],4.264300312163491e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27314,2948,0.82 [0.75-0.89],5.648261773416084e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27654,1402,0.82 [0.72-0.93],0.0015297003785566
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27843,93,1.15 [0.71-1.89],0.5702647432164644
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26053,843,0.82 [0.70-0.97],0.0175273370897794
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25188,981,0.75 [0.64-0.87],0.0001256517347995
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25211,264,0.68 [0.51-0.90],0.0079268805292555
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19616,1715,0.81 [0.73-0.91],0.0004155830674806
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24976,383,0.57 [0.45-0.72],2.1662553394982017e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27886,1634,0.83 [0.74-0.93],0.0017924978414779
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,28015,547,0.74 [0.60-0.90],0.0024336433440821
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27238,977,0.77 [0.66-0.90],0.0007195264451496
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27960,930,0.87 [0.75-1.02],0.0859034012196777
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26458,206,1.04 [0.75-1.45],0.8138341405660561
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28078,47,1.79 [0.89-3.56],0.1001825043276762
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27845,815,0.83 [0.71-0.98],0.0272871643290507
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27832,82,1.22 [0.72-2.08],0.452473780646863
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27977,197,0.61 [0.44-0.84],0.0025858799942287
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27958,178,0.61 [0.43-0.86],0.0042597635635236
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26614,353,1.10 [0.86-1.42],0.4459614146324492
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26533,272,0.62 [0.47-0.82],0.0008751127365163
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26384,132,0.64 [0.43-0.94],0.024615787588706
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28054,36,1.90 [0.86-4.19],0.1124057584659157
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28001,160,0.62 [0.43-0.89],0.0092227180616685
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral warts,27888,47,0.63 [0.32-1.24],0.181625829708275
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27920,79,0.58 [0.35-0.96],0.0345734102435538
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm,27801,246,0.96 [0.71-1.30],0.7735056636453391
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27972,71,1.21 [0.68-2.14],0.5118463005746465
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27968,72,0.95 [0.54-1.66],0.8483979553777259
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27783,1248,0.92 [0.80-1.05],0.2151029327027949
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of meninges,28050,83,0.84 [0.50-1.41],0.5064110740310226
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28010,67,0.92 [0.51-1.64],0.7738330866196799
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28044,137,1.10 [0.73-1.66],0.636262768201
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm of ovary,27992,181,0.76 [0.53-1.07],0.1141484494770936
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28056,284,0.86 [0.65-1.14],0.3055850459786851
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Caecum,28063,254,0.93 [0.69-1.26],0.6540377228823175
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27988,66,0.78 [0.44-1.38],0.3937839688862109
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Descending colon,28059,158,0.78 [0.54-1.13],0.1882845223971886
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Rectum,28019,287,1.01 [0.76-1.33],0.9622884627541536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27970,504,0.90 [0.72-1.11],0.3032045878446431
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28058,302,0.83 [0.63-1.09],0.1773206969226973
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Carcinoma in situ of breast,22764,139,0.88 [0.59-1.33],0.5536015135549479
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22856,169,0.69 [0.48-0.99],0.0435289110719248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22835,33,0.74 [0.33-1.67],0.4655681348958627
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22871,69,0.75 [0.43-1.31],0.3103298744655748
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28008,139,1.08 [0.72-1.61],0.7241790642151117
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Haemangioma, any site",28009,137,1.05 [0.70-1.59],0.7976150630933894
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Leiomyoma of uterus,27067,598,1.12 [0.92-1.36],0.2700438688284881
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lung cancer and mesothelioma,20139,320,0.61 [0.47-0.78],9.341243727542226e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lymphoid leukaemia,22840,38,0.89 [0.41-1.94],0.776657133721486
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22982,180,1.20 [0.84-1.72],0.3157653759741178
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22918,116,0.59 [0.39-0.89],0.0127968131077721
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22992,190,1.26 [0.89-1.78],0.1967897780844493
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22873,71,0.86 [0.49-1.50],0.5886752252637499
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22876,74,1.04 [0.60-1.80],0.8981238367527418
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22860,58,0.45 [0.26-0.78],0.0045594203565417
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22946,144,0.97 [0.65-1.44],0.8804201757173203
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22906,104,0.61 [0.39-0.94],0.0269457839586069
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22888,86,0.67 [0.41-1.09],0.1077295696716287
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22845,43,0.54 [0.28-1.05],0.0689774299745793
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22885,83,0.77 [0.46-1.28],0.3072755546665038
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi,27811,236,1.01 [0.74-1.38],0.9357602078324304
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanocytic naevi of trunk,28030,82,0.87 [0.51-1.46],0.589394125156816
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Melanoma in situ,22837,90,0.76 [0.46-1.24],0.2647507743885977
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22886,84,0.75 [0.45-1.25],0.2750270242084879
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22959,157,0.93 [0.63-1.36],0.7038810226405099
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",23035,233,0.67 [0.50-0.90],0.0077605445208005
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22899,97,1.15 [0.70-1.87],0.5854015722887509
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Other benign neoplasms of skin,27847,171,0.95 [0.66-1.37],0.7920020425083217
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23762,960,1.07 [0.91-1.24],0.4214904458925571
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23803,1001,1.09 [0.94-1.27],0.2665517260557756
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27768,382,1.07 [0.84-1.37],0.5782236150435272
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26000,105,0.80 [0.51-1.27],0.3503306867302519
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27456,70,0.80 [0.46-1.39],0.42498430984461
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27035,3046,0.89 [0.82-0.97],0.0097413816440637
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26390,36,0.53 [0.25-1.11],0.0940687753817952
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27662,46,1.32 [0.65-2.67],0.4461105173265424
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27475,1580,0.88 [0.78-0.99],0.0282428155564896
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27475,1580,0.88 [0.78-0.99],0.0282428155564896
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25967,72,0.78 [0.45-1.36],0.3907110717125371
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27657,1303,0.84 [0.74-0.96],0.0096032782767413
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27739,123,0.61 [0.40-0.92],0.018818052134585
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27436,50,1.12 [0.57-2.19],0.7377807987229807
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27444,58,1.10 [0.59-2.06],0.7550443864583171
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27857,241,0.93 [0.68-1.26],0.6368289525951123
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27962,62,1.82 [0.99-3.34],0.0549113636042767
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27821,205,0.98 [0.70-1.37],0.9121281363324428
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26492,138,0.95 [0.64-1.43],0.8143828114705537
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22598,260,0.54 [0.41-0.71],9.816431505950028e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26618,71,0.94 [0.53-1.67],0.8449253838501177
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26613,66,0.72 [0.41-1.27],0.2535961670510772
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22391,53,0.38 [0.22-0.68],0.0009844231141154
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25739,73,0.79 [0.46-1.37],0.4092004642559006
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25373,253,1.14 [0.84-1.54],0.3910303661302805
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27631,522,0.74 [0.61-0.91],0.0042163954179207
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27401,292,0.88 [0.66-1.16],0.3489221891206651
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27197,88,0.59 [0.37-0.96],0.0329050062897182
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27666,2000,0.94 [0.85-1.05],0.2814728471639478
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24834,1948,0.90 [0.81-1.00],0.0576535183318153
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22398,60,0.74 [0.40-1.35],0.3267384472491178
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24897,121,1.25 [0.81-1.94],0.3110958015861736
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22628,290,0.59 [0.45-0.77],8.977593726020703e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22386,48,1.18 [0.58-2.37],0.6482257374857561
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25564,3226,0.79 [0.73-0.86],4.308535339375973e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22540,202,0.61 [0.44-0.84],0.0025139560631276
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22882,544,0.63 [0.52-0.77],6.181518436667376e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27972,378,0.65 [0.52-0.83],0.0004093259967507
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27781,187,1.05 [0.74-1.49],0.7735619604057979
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22439,101,0.58 [0.37-0.91],0.0177415386532469
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22394,56,0.67 [0.36-1.25],0.2102047596896812
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27164,2388,1.01 [0.91-1.11],0.8617098946886375
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22548,210,0.68 [0.50-0.94],0.0191181444156754
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22556,218,1.04 [0.75-1.44],0.8270866319689208
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22883,545,0.77 [0.63-0.94],0.0117777358561451
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22432,94,0.60 [0.38-0.97],0.0380853619734147
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27771,177,1.09 [0.76-1.56],0.6380610850788611
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22980,642,0.52 [0.44-0.63],6.57355948620812e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22912,574,0.67 [0.55-0.81],4.413882827783143e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25192,72,0.57 [0.33-0.97],0.0375351370017209
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27148,4810,0.79 [0.74-0.85],1.1904785716277824e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24855,79,0.85 [0.50-1.44],0.5442473200060983
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24865,89,0.54 [0.34-0.86],0.0101394429152902
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27874,2137,0.83 [0.75-0.92],0.0003450801652533
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27880,2137,0.83 [0.75-0.92],0.0003344249183769
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24858,82,1.05 [0.62-1.78],0.8579807332714264
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27655,1630,0.84 [0.75-0.95],0.0041139805305246
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23893,1555,0.62 [0.55-0.70],8.820261966938157e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28063,188,0.58 [0.42-0.81],0.0012876696959947
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27167,58,0.77 [0.42-1.42],0.4071916385036106
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26159,134,0.96 [0.64-1.45],0.8434592175409482
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26228,203,0.95 [0.68-1.32],0.7590752853711743
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22611,273,0.89 [0.67-1.20],0.449589992554894
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26201,144,0.57 [0.39-0.83],0.0036391430878635
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1751,50,1.35 [0.69-2.62],0.3803293883556736
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1864,187,1.06 [0.75-1.49],0.7526587390535842
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26083,26,0.47 [0.20-1.12],0.0870768866689394
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1732,32,1.54 [0.66-3.58],0.3191404519418641
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27577,1520,0.60 [0.54-0.68],1.991122915074191e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27456,347,0.93 [0.72-1.20],0.5712314817094233
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25617,497,0.95 [0.77-1.18],0.6550406552482626
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,23081,743,0.67 [0.57-0.80],5.297987597021908e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27974,235,1.07 [0.78-1.45],0.6864547723819023
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27038,55,0.65 [0.35-1.20],0.1701126104560142
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,26508,901,0.92 [0.78-1.07],0.2743718131208201
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27082,99,1.05 [0.65-1.68],0.8406487600746546
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27018,35,0.85 [0.39-1.86],0.690268599822432
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27138,155,0.65 [0.45-0.93],0.01937412082885
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18240,1512,0.86 [0.76-0.97],0.0154568520333943
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,AV-block,24585,249,0.78 [0.58-1.06],0.1090946157340215
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28034,311,0.90 [0.69-1.17],0.4213717240760687
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiac arrest,16860,132,1.37 [0.90-2.10],0.1422789446958554
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24476,140,1.15 [0.76-1.72],0.5116632313121263
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",24418,82,1.02 [0.60-1.72],0.955225279359852
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28073,35,0.86 [0.39-1.85],0.6928356469879189
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Conduction disorders,25087,751,0.93 [0.78-1.10],0.3959067703155513
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27140,1545,0.86 [0.76-0.96],0.0108874977777469
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25236,7439,0.84 [0.79-0.89],6.470927079553426e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26523,250,1.00 [0.74-1.35],0.991189019523488
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Endocarditis,24399,63,0.60 [0.34-1.07],0.0856089227681336
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27977,879,0.94 [0.80-1.10],0.4471435062705402
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,25876,6288,0.79 [0.74-0.84],1.0306038561328523e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25889,6301,0.79 [0.74-0.84],8.19158129979184e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27961,42,0.98 [0.47-2.02],0.9546339278876568
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19755,167,0.71 [0.49-1.03],0.0697352703306749
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19694,106,0.50 [0.32-0.78],0.0024599003071179
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,27933,1130,0.73 [0.64-0.84],8.388931648221907e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27300,97,0.70 [0.44-1.12],0.1332498802790453
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27340,1733,0.88 [0.79-0.99],0.030070035251016
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27752,467,0.84 [0.68-1.04],0.111528708874052
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24643,307,1.08 [0.82-1.42],0.5796473313942339
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27848,620,0.77 [0.64-0.93],0.0060577332971045
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26105,498,0.73 [0.59-0.89],0.0026158490915757
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28051,90,0.87 [0.53-1.43],0.5866014047443642
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28071,246,0.62 [0.46-0.82],0.00100182631868
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Oesophageal varices,26310,37,0.73 [0.34-1.55],0.408126679488307
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other aneurysm,27044,61,1.49 [0.80-2.75],0.2053312152703183
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arrhythmias,24701,365,0.98 [0.76-1.26],0.8823647343920841
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27051,68,0.83 [0.47-1.45],0.5058219673973309
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27181,198,0.67 [0.49-0.94],0.0183028993715243
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24498,162,1.03 [0.71-1.49],0.8914199551569414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other disorders of veins,26371,98,1.06 [0.66-1.71],0.8078988730525593
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26319,46,0.67 [0.34-1.33],0.2545890212575341
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26792,40,0.35 [0.19-0.66],0.0011678925162832
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26443,170,0.84 [0.59-1.20],0.3459949827928132
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25164,828,0.86 [0.73-1.01],0.0633242552628102
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26847,44,0.63 [0.32-1.26],0.1900212447459613
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27497,514,0.90 [0.73-1.11],0.3072164584908889
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27482,328,0.78 [0.60-1.01],0.0555126624137161
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27315,563,0.70 [0.58-0.85],0.0003296402322456
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,17025,297,0.82 [0.62-1.08],0.1578486523817362
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27249,280,0.86 [0.65-1.14],0.3062109347053783
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26605,332,1.02 [0.78-1.32],0.9017130781648948
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27614,460,0.85 [0.68-1.06],0.145259706468265
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27999,604,0.75 [0.62-0.91],0.0028465458544743
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24563,227,0.93 [0.68-1.28],0.6558277646644388
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27473,319,0.80 [0.62-1.04],0.0906557074009138
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26917,165,0.77 [0.54-1.11],0.1595530720854976
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27745,542,0.82 [0.67-1.00],0.054364764360278
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27719,590,0.86 [0.71-1.04],0.1269730550773997
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27265,72,1.04 [0.60-1.81],0.8947601810379547
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27030,47,1.83 [0.91-3.68],0.0874527098415658
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27510,225,0.68 [0.50-0.92],0.0118251581352536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27433,205,0.75 [0.54-1.04],0.086761081737681
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,26743,470,1.25 [1.00-1.56],0.0489752597830152
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26996,98,0.89 [0.56-1.44],0.6448868417509492
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27858,723,0.92 [0.77-1.10],0.3595665084089724
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28032,224,1.14 [0.83-1.57],0.4099131477103815
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24924,1902,0.83 [0.75-0.93],0.001008822711385
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,27449,4427,0.86 [0.80-0.93],3.871468318236554e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28000,267,1.14 [0.85-1.52],0.3810441778012288
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25044,2022,0.91 [0.82-1.02],0.0989375946178369
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23117,95,0.64 [0.40-1.03],0.0651895270603846
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,27653,1224,0.75 [0.66-0.86],1.4879969133798878e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24435,1413,0.80 [0.70-0.90],0.0002755961968883
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Vascular dementia,27563,104,0.68 [0.43-1.06],0.0896091300270105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Alzheimer disease,28077,365,0.83 [0.65-1.06],0.1396266955178787
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",19142,59,0.89 [0.48-1.63],0.6970393776961834
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Bell's palsy,25860,88,0.54 [0.34-0.87],0.0104583699820403
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26420,648,0.95 [0.79-1.15],0.5958755143329642
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral cysts,27662,226,0.84 [0.61-1.15],0.265879888935437
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28003,286,0.84 [0.63-1.10],0.2028474125990309
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27581,40,0.75 [0.36-1.57],0.4410538612162661
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28063,47,0.43 [0.23-0.79],0.0066210871726209
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27492,56,0.94 [0.50-1.78],0.8545415975831002
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Epilepsy,26543,287,0.71 [0.54-0.93],0.0136457317855601
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27647,1391,0.88 [0.77-1.00],0.0437267340576362
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28027,527,0.84 [0.69-1.03],0.1005934727045726
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27425,2974,0.84 [0.77-0.92],9.838297566626336e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Generalized epilepsy,27699,48,0.70 [0.36-1.37],0.2961753650998868
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hemiplegia,27945,228,0.84 [0.61-1.14],0.2610484408609222
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Hydrocephalus,27504,68,0.70 [0.40-1.23],0.2139347483586961
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28057,79,0.46 [0.29-0.75],0.0016969925858512
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25902,130,0.84 [0.55-1.27],0.3960467313886714
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25840,68,1.37 [0.77-2.44],0.2793090941709624
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Memory loss,27433,99,0.93 [0.58-1.50],0.7742335877504752
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Migraine,26783,527,1.05 [0.85-1.29],0.6586472356300432
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27958,473,1.01 [0.81-1.26],0.8979775535632759
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Motor neuron disease,19232,122,0.75 [0.48-1.15],0.1861085435274237
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27850,145,0.57 [0.39-0.83],0.0030975216104803
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27202,1430,0.83 [0.73-0.94],0.0036700153487431
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,26415,3901,0.83 [0.77-0.90],2.9852756035961085e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27703,162,0.75 [0.52-1.09],0.1281575876786484
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26209,437,0.67 [0.54-0.84],0.0004701611629757
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28019,240,0.86 [0.64-1.17],0.3321483507325312
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22597,677,0.72 [0.60-0.86],0.0003190301131417
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27505,69,0.64 [0.37-1.11],0.1133510955085601
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27561,125,0.70 [0.46-1.06],0.0894453798903722
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27689,189,0.95 [0.68-1.35],0.7890318402403323
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25870,98,0.49 [0.32-0.76],0.0013314624616975
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other headache syndromes,26333,77,0.77 [0.45-1.32],0.3406199816200521
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,27953,517,0.79 [0.65-0.97],0.0277062508159648
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,26676,420,0.93 [0.74-1.17],0.532858670387808
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Parkinson's disease,28052,321,0.81 [0.63-1.06],0.1214045169905781
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27520,84,0.65 [0.39-1.07],0.0923775590594014
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Restless leg syndrome,28076,106,0.99 [0.62-1.57],0.9674018598538512
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Sleep apnoea,27893,332,0.96 [0.74-1.25],0.7714701758522273
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27819,40,0.86 [0.41-1.82],0.696191070129028
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28067,151,0.78 [0.53-1.15],0.2083847381139926
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25841,69,0.83 [0.47-1.46],0.5070157493604044
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28077,369,0.83 [0.65-1.06],0.1364743027444465
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27518,101,0.73 [0.46-1.15],0.1716444025315643
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27477,112,0.89 [0.57-1.38],0.5935411947162361
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27599,495,0.93 [0.75-1.16],0.5347111657182453
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27928,175,0.77 [0.54-1.10],0.1485733271655448
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26939,63,0.74 [0.41-1.32],0.3053547705817562
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26930,54,1.34 [0.70-2.58],0.3750162580312576
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27952,61,1.25 [0.68-2.30],0.4759816952081785
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27784,170,0.75 [0.52-1.07],0.1116645332786893
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1738,37,1.86 [0.86-4.05],0.1170615301632923
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2090,72,1.75 [1.04-2.97],0.0364046526993742
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27458,93,0.83 [0.51-1.36],0.4633945659037675
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27894,1082,0.93 [0.80-1.07],0.3031696815893707
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27646,770,0.90 [0.76-1.07],0.233346880666082
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27179,303,0.80 [0.61-1.05],0.1137792757951094
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27982,878,0.92 [0.78-1.07],0.2790312894226999
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28060,71,1.23 [0.70-2.17],0.4769195961603797
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27902,798,0.91 [0.77-1.08],0.2884160506070444
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28029,415,0.78 [0.62-0.98],0.0314032657268763
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27979,212,0.68 [0.50-0.94],0.0182575683663418
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26917,41,1.18 [0.56-2.50],0.6618095773097059
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26923,47,0.81 [0.41-1.60],0.5360852880725554
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26942,66,0.97 [0.54-1.75],0.9225078086204354
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27988,744,1.02 [0.85-1.21],0.8583676401105513
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27434,190,1.16 [0.82-1.64],0.4129173026103822
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27174,70,0.99 [0.56-1.75],0.967565113480266
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27718,104,1.16 [0.72-1.85],0.5458644499220298
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27934,320,0.70 [0.54-0.90],0.0063969637491453
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27320,216,0.86 [0.63-1.19],0.3758740815759891
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27906,139,0.60 [0.41-0.88],0.0095086919016192
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27733,489,0.93 [0.75-1.16],0.5286130310706038
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27520,155,0.89 [0.61-1.29],0.5310951225431944
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26235,2571,0.86 [0.79-0.95],0.0023987956060907
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27893,279,0.71 [0.54-0.94],0.017490357948579
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28051,159,0.86 [0.59-1.26],0.4443307848304562
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27279,403,1.00 [0.79-1.27],0.9881193907709184
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27678,64,1.06 [0.58-1.92],0.8558005037621614
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28045,56,1.41 [0.75-2.68],0.2869504999325987
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26969,93,0.93 [0.57-1.52],0.771929905213281
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27035,159,1.38 [0.95-2.02],0.0937110465740393
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26920,108,0.99 [0.62-1.56],0.9487530460829272
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27177,73,0.93 [0.54-1.63],0.8129375162031556
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26874,62,1.03 [0.56-1.90],0.9174173357796284
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27367,123,0.75 [0.49-1.14],0.1790639084777476
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27428,184,1.00 [0.70-1.42],0.9838368141560196
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27013,137,0.84 [0.56-1.26],0.3960435987504963
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26912,100,1.05 [0.65-1.70],0.8414689156619921
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26888,76,0.92 [0.53-1.58],0.751361820599594
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25811,2147,0.81 [0.73-0.89],3.289479504415125e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26962,86,1.27 [0.75-2.13],0.3742905494534438
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27804,439,0.83 [0.67-1.04],0.109494306721108
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27414,49,0.90 [0.46-1.76],0.7540694061650414
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27538,173,0.82 [0.57-1.17],0.2742549330895075
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27829,117,0.97 [0.62-1.50],0.8758419717459919
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28029,120,1.10 [0.71-1.70],0.6705623477204414
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27947,147,0.61 [0.42-0.88],0.0089838780447654
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27781,69,0.69 [0.40-1.20],0.1910869686670793
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27784,72,1.26 [0.72-2.21],0.4227163905590085
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27974,836,0.90 [0.76-1.06],0.2074025837414219
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27710,572,0.97 [0.79-1.18],0.7521505040568659
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27263,125,0.93 [0.61-1.42],0.7308930954385717
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27226,88,0.47 [0.30-0.75],0.0014386799513727
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute pharyngitis,27800,88,0.68 [0.42-1.12],0.1284238278396627
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27949,237,0.79 [0.58-1.07],0.1309180217740945
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27777,65,0.77 [0.43-1.37],0.3692723004882706
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,All influenza,26312,131,0.93 [0.61-1.41],0.7311910854598164
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26310,129,0.93 [0.61-1.42],0.7476870210750834
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19948,129,0.69 [0.45-1.05],0.0835358106978221
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Allergic rhinitis,27918,294,0.86 [0.65-1.14],0.2879705184245061
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21742,2117,0.76 [0.68-0.84],1.293673532711766e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21909,2090,0.75 [0.68-0.83],9.231278458220048e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27648,128,0.65 [0.43-0.98],0.0375486499969813
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26249,68,0.55 [0.32-0.95],0.0321713651656241
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bronchiectasis,24274,419,0.71 [0.56-0.89],0.0032866998356272
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23928,73,0.57 [0.33-0.98],0.0414748578976301
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26893,3038,0.75 [0.69-0.82],7.825251661478305e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26766,62,1.19 [0.65-2.20],0.5777191118686539
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic sinusitis,26854,150,1.16 [0.78-1.71],0.4697366327974233
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27898,1087,0.68 [0.60-0.79],7.062199045192466e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Deviated nasal septum,26779,75,0.79 [0.46-1.37],0.4060933824348536
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25943,5286,0.81 [0.75-0.86],9.306207742019208e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27043,339,0.83 [0.64-1.07],0.1419712820318356
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,27137,326,0.66 [0.52-0.85],0.0013511790988379
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Emphysema,24137,282,0.64 [0.49-0.84],0.0010702023287098
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26404,236,0.57 [0.42-0.77],0.0002605109299501
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27879,1698,0.72 [0.64-0.81],1.0099057555186296e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,26445,277,0.58 [0.44-0.76],0.0001129584020774
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Later onset COPD,27138,761,0.70 [0.59-0.83],2.392764354251035e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28069,232,0.65 [0.48-0.87],0.0041611945378293
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Nasal polyp,26774,70,0.95 [0.54-1.68],0.868744851400336
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27846,943,0.79 [0.68-0.92],0.0022742138177834
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,27883,1796,0.79 [0.70-0.88],1.7358949144751688e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27508,804,0.86 [0.73-1.02],0.0788669486529339
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other pleural conditions,26124,37,0.58 [0.27-1.23],0.1535631147710872
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27996,353,0.63 [0.50-0.80],0.0001907571256372
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27985,1211,0.74 [0.65-0.85],1.2375587552887892e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,26959,872,0.81 [0.69-0.95],0.0107603667930436
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural plaque,26133,46,1.19 [0.59-2.39],0.6306728613741092
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27637,1456,0.70 [0.62-0.78],4.04997086549428e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28038,201,0.62 [0.45-0.85],0.0030840949848886
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pneumothorax,26181,94,1.00 [0.61-1.63],0.9955490214740804
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pollen allergy,28044,246,0.82 [0.61-1.11],0.2066023923380162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pulmonary oedema,27707,64,0.53 [0.31-0.93],0.026310726272772
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19872,53,0.61 [0.32-1.14],0.1216574430034246
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27821,918,0.77 [0.66-0.90],0.0009637424466302
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26998,294,0.86 [0.65-1.13],0.2794776093186892
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Viral pneumonia,26400,219,0.65 [0.48-0.89],0.0068662629679636
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27658,173,0.67 [0.47-0.95],0.0258311142828812
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13562,110,0.64 [0.41-1.01],0.0534950878556846
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,20021,39,0.84 [0.39-1.78],0.6409492660590741
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute appendicitis,27888,148,1.67 [1.12-2.48],0.0110400530240528
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute gastritis,21062,88,0.74 [0.45-1.23],0.24556990897813
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute pancreatitis,25717,166,0.80 [0.55-1.15],0.2210395258638209
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Acute peritonitis,27491,87,0.89 [0.54-1.48],0.6601423842669232
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27177,34,0.42 [0.21-0.87],0.0193130709156581
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Barrett oesophagus,21319,345,0.74 [0.58-0.96],0.0220858434302319
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25631,80,0.83 [0.49-1.41],0.4951572552936844
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27638,80,0.85 [0.50-1.43],0.5320171678003118
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholecystitis,25743,192,0.84 [0.60-1.18],0.3232037699045386
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Cholelithiasis,26765,1214,0.92 [0.80-1.05],0.2065813864585326
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic gastritis,21325,351,0.95 [0.74-1.23],0.7210286632006117
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25594,43,0.53 [0.27-1.04],0.063341516504882
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27991,72,0.58 [0.34-0.99],0.046603363372078
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Coeliac disease,26481,156,1.18 [0.80-1.74],0.3967982187252037
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Collagenous colitis,26141,116,0.92 [0.59-1.44],0.7143222619990657
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27934,152,0.97 [0.66-1.43],0.8959449131078648
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,27723,1769,0.82 [0.73-0.91],0.000434590062147
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,26119,94,0.49 [0.31-0.77],0.0019462143312168
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27708,70,0.70 [0.40-1.22],0.2033880256991721
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26123,98,0.45 [0.29-0.70],0.0003664182700154
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,27229,234,0.62 [0.46-0.83],0.0015852741438356
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26412,2519,0.83 [0.76-0.92],0.0001422528951291
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of appendix,27931,191,1.40 [0.99-1.99],0.0572756847508142
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of liver,27972,829,0.81 [0.69-0.95],0.0106503181812792
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25722,4748,0.89 [0.83-0.96],0.0015225892449248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27597,602,0.83 [0.68-1.00],0.0542079262337058
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27953,549,0.96 [0.78-1.17],0.6668622478319954
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27116,121,1.21 [0.78-1.87],0.3886164518918606
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26960,65,1.03 [0.57-1.85],0.9249097847728416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27767,1442,0.98 [0.87-1.12],0.8006680051495849
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diseases of tongue,26971,114,0.98 [0.63-1.54],0.9432168964301284
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27181,1630,0.87 [0.77-0.98],0.0175817162213971
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23265,3283,0.82 [0.75-0.89],1.9214510798424893e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Duodenal ulcer,21106,132,0.80 [0.53-1.21],0.2858653391968445
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28024,111,0.81 [0.52-1.27],0.3543987825935212
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27971,65,0.88 [0.49-1.60],0.6786925616982133
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27237,94,0.65 [0.40-1.03],0.0682079738949057
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,20096,114,1.07 [0.68-1.69],0.7586524047723391
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,21651,677,0.79 [0.65-0.94],0.0101432499350294
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,21327,353,0.75 [0.58-0.96],0.0234680360685451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23841,2867,0.82 [0.75-0.90],1.7205923768707536e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21453,479,0.76 [0.61-0.94],0.0129990545042825
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21966,8669,0.92 [0.88-0.97],0.0029633566712556
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,GI-bleeding,27490,1165,1.00 [0.87-1.15],0.9953068887469844
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27058,63,0.76 [0.42-1.36],0.3544757863670036
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20975,1295,0.88 [0.77-1.01],0.0719468931803269
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27183,40,0.62 [0.30-1.27],0.1898936044226416
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,26856,2963,0.82 [0.75-0.89],3.990566998015576e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impacted teeth,27982,60,0.93 [0.50-1.72],0.8079984201302086
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Impaction of intestines,20048,66,0.69 [0.39-1.23],0.2048085770539904
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Inguinal hernia,24062,169,0.94 [0.65-1.35],0.7305974861111215
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,20087,105,0.61 [0.39-0.95],0.029317002133343
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26507,182,1.24 [0.86-1.77],0.2454993556622727
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20822,840,0.76 [0.65-0.90],0.0012960995574441
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28061,367,0.69 [0.54-0.87],0.0019924497092027
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26863,838,0.86 [0.73-1.01],0.0689340377683578
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27155,1130,0.86 [0.74-0.99],0.0311184894668094
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21138,164,0.88 [0.60-1.28],0.500676989827872
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oesophagitis,21554,580,0.75 [0.61-0.91],0.0037578983740201
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28029,161,0.99 [0.68-1.45],0.9696414262979748
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23953,60,0.57 [0.32-1.01],0.0547436804449351
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21284,1302,0.86 [0.75-0.98],0.026705488455179
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25858,307,0.63 [0.49-0.82],0.0005612096719513
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25746,195,0.93 [0.66-1.31],0.6824220751079317
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,21603,1621,0.75 [0.66-0.84],8.593603274095167e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,25847,5865,0.85 [0.80-0.90],2.873834999233661e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26962,235,0.97 [0.71-1.32],0.8226876852437353
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of liver,27840,697,0.85 [0.71-1.01],0.0646790597185324
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21568,594,0.78 [0.64-0.95],0.0137011793636768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25711,160,1.09 [0.75-1.60],0.6399598109146057
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27890,486,0.97 [0.78-1.20],0.7508498557527103
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22083,1109,0.83 [0.72-0.95],0.0096168904274829
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27509,1184,1.00 [0.87-1.15],0.9698504666835428
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27192,197,0.89 [0.63-1.24],0.486171574091512
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21807,1825,0.79 [0.71-0.89],3.793323280796891e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23141,2167,0.88 [0.79-0.98],0.0156307942811162
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27243,100,0.44 [0.29-0.68],0.0001668321295664
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27020,995,0.86 [0.74-1.00],0.0439031137930253
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20320,338,0.67 [0.52-0.86],0.0020046108394627
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27960,75,0.86 [0.50-1.49],0.5902781304092777
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20489,507,0.76 [0.61-0.93],0.0091539056473147
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26460,135,0.67 [0.45-0.99],0.0445686489171024
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28069,71,1.14 [0.64-2.00],0.6601544021648995
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26997,130,1.09 [0.72-1.66],0.6848139079215878
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Toxic colitis,26093,68,0.60 [0.34-1.05],0.072039439571273
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21211,237,0.77 [0.57-1.05],0.0968840271704466
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcerative colitis,26198,173,0.90 [0.62-1.29],0.5538536886953631
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26167,142,0.93 [0.63-1.40],0.7428067339860742
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Umbilical hernia,24066,173,0.87 [0.61-1.25],0.4493513850889895
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,20176,194,0.79 [0.56-1.11],0.1679111600624464
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ventral hernia,24152,259,0.68 [0.51-0.91],0.0090234862530165
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Volvulus,20069,87,1.16 [0.69-1.95],0.5705940763009589
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27987,266,0.64 [0.48-0.85],0.0020385806278486
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27746,79,1.35 [0.79-2.31],0.2757325658284358
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25959,225,0.82 [0.59-1.12],0.21543833470034
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27531,648,0.80 [0.67-0.97],0.0204805026207022
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27032,149,1.07 [0.73-1.59],0.7170623889466318
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26082,348,0.54 [0.43-0.69],5.382718115733338e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27753,288,1.21 [0.91-1.60],0.1821264678561251
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27962,497,1.09 [0.88-1.35],0.4412695899497323
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27517,52,0.96 [0.50-1.84],0.8934793094358281
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26431,3252,0.92 [0.84-1.00],0.0413394203136922
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27615,493,1.00 [0.81-1.25],0.9642920295033656
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27461,339,0.90 [0.70-1.17],0.4317952115688629
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27750,867,0.84 [0.71-0.98],0.0294086647370171
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28052,79,0.79 [0.47-1.35],0.3866974456228397
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25825,91,0.37 [0.24-0.57],5.950223451658179e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27170,48,1.26 [0.63-2.50],0.5177685613756169
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27738,273,1.31 [0.98-1.75],0.0658440072565634
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26161,427,0.99 [0.78-1.25],0.9259376616542724
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25782,48,1.08 [0.54-2.15],0.8314613810509202
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27969,85,0.46 [0.29-0.73],0.0009078506184382
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27045,162,0.85 [0.59-1.23],0.390196724507348
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27838,171,1.19 [0.83-1.71],0.3536138063280648
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27523,58,0.74 [0.40-1.36],0.3286859605939662
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25802,68,0.86 [0.49-1.54],0.6203951416491938
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27369,1635,0.82 [0.73-0.92],0.0010543030682834
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26197,463,0.99 [0.79-1.23],0.8976492837707459
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25787,53,1.12 [0.58-2.17],0.7300393590815089
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27987,320,1.03 [0.79-1.34],0.8347697077693818
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27550,85,0.74 [0.45-1.23],0.2496677348787575
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27912,245,1.15 [0.85-1.56],0.3574640744312484
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28024,303,0.66 [0.50-0.86],0.0018860780441143
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25898,164,0.81 [0.56-1.18],0.2674146154702627
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26000,266,0.87 [0.65-1.17],0.3539866131271069
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28009,288,0.64 [0.49-0.84],0.0014761825525987
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25942,208,0.80 [0.58-1.11],0.1875934505592231
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28040,156,0.72 [0.49-1.04],0.07761740876334
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23948,130,1.13 [0.74-1.73],0.5736015552397273
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25494,6556,0.86 [0.81-0.91],8.066084233539768e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24062,5124,0.85 [0.80-0.91],1.7140286704910765e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23899,81,0.87 [0.51-1.48],0.6144204262061743
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24072,156,0.87 [0.59-1.27],0.4712550925248451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24133,217,0.95 [0.68-1.31],0.7487670050399392
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27778,117,1.42 [0.91-2.22],0.1195612173161854
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24036,120,0.79 [0.51-1.21],0.2741332449676986
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20348,1410,0.93 [0.82-1.06],0.2926615151736078
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27921,229,1.14 [0.83-1.57],0.4011073895644711
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24539,623,0.68 [0.57-0.82],6.0655045441717136e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23592,8328,0.87 [0.83-0.92],2.83317554022537e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25159,144,0.78 [0.53-1.16],0.2214896772096547
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23956,138,1.26 [0.84-1.89],0.267925468754827
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24526,708,0.83 [0.69-0.99],0.0417127097661709
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27027,3111,0.78 [0.72-0.85],1.0833257929629e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24000,182,1.09 [0.76-1.55],0.6449600645614924
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24207,389,0.86 [0.68-1.10],0.2264376826909729
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23993,175,0.62 [0.44-0.88],0.0080111408067195
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27100,111,0.54 [0.35-0.83],0.0054399282247848
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20869,1931,0.78 [0.70-0.87],7.677382602563031e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19166,228,0.75 [0.55-1.03],0.0749910217930289
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28064,225,0.84 [0.61-1.14],0.2614458747736397
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,19041,103,0.53 [0.34-0.84],0.0064228708545188
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19526,588,0.92 [0.76-1.13],0.4409059677474385
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24159,341,0.85 [0.66-1.10],0.2168278561056721
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19592,654,0.93 [0.77-1.13],0.4630242745509174
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23985,69,0.69 [0.39-1.22],0.2042648539901685
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24649,733,0.68 [0.57-0.80],9.04819569350268e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24259,343,0.79 [0.61-1.02],0.0680603012657768
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19548,610,0.91 [0.75-1.11],0.3617048779909912
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23914,96,0.93 [0.57-1.52],0.7816153329536271
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23889,71,0.66 [0.38-1.14],0.132742996588101
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,25065,50,0.73 [0.37-1.41],0.3450794634588134
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27586,2571,0.83 [0.75-0.91],5.525659658579128e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26863,1848,0.81 [0.73-0.91],0.0002035164400571
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27872,621,0.72 [0.59-0.86],0.0005085853895321
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22057,3119,0.79 [0.73-0.86],9.753230386958344e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,19013,75,0.96 [0.55-1.67],0.8734584107227001
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23922,104,0.81 [0.51-1.29],0.3825310890886808
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18982,44,0.49 [0.25-0.96],0.0380117852333532
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19144,206,0.61 [0.44-0.84],0.0026326073156863
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25315,300,0.87 [0.66-1.15],0.3400168318876066
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25615,600,0.79 [0.65-0.96],0.0176549312327384
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28046,117,0.71 [0.47-1.10],0.1237340335813266
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26014,2098,0.74 [0.67-0.82],6.609965052697451e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23955,137,0.72 [0.48-1.07],0.1067422607009271
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19176,238,1.14 [0.83-1.56],0.418487320987704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24754,838,0.72 [0.61-0.85],7.88731011186936e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21558,2620,0.80 [0.73-0.88],2.23633867947851e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27124,135,0.67 [0.45-1.00],0.0489180543873786
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28057,78,1.38 [0.80-2.37],0.2408411462615555
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23901,83,0.86 [0.51-1.44],0.5587758570027948
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25340,1522,0.90 [0.80-1.02],0.0872252986591239
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23903,85,1.07 [0.64-1.80],0.7988964639600248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20991,2053,0.76 [0.69-0.85],5.701274936843648e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25154,139,0.68 [0.46-1.02],0.0616644615140113
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23882,64,0.89 [0.49-1.63],0.7172036633428613
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24124,208,0.83 [0.60-1.15],0.2621269809554369
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24426,608,1.00 [0.82-1.21],0.9675945342823152
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27511,522,0.82 [0.67-1.01],0.0658991862823422
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24582,666,0.79 [0.66-0.95],0.0139407938373284
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27887,601,0.70 [0.58-0.84],0.0002106967928014
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28047,70,0.84 [0.48-1.47],0.5378689268219465
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24050,232,0.88 [0.65-1.21],0.4448045054715734
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21544,947,0.75 [0.64-0.87],0.0002328953925871
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24505,687,0.83 [0.69-0.99],0.0397851161218498
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23944,126,1.08 [0.70-1.66],0.7184379229907116
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",19016,78,0.71 [0.41-1.21],0.2066733711311451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21660,2722,0.78 [0.71-0.86],1.2223314199876282e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19802,864,0.77 [0.66-0.91],0.0018532264396736
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27296,307,0.69 [0.53-0.90],0.0070449374270966
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28016,87,0.64 [0.39-1.05],0.0775606940290261
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25710,57,1.19 [0.64-2.21],0.5839268224043893
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,19017,79,1.28 [0.74-2.20],0.3802858872625387
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24031,115,1.48 [0.94-2.31],0.0883681803410879
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19563,625,0.69 [0.58-0.84],0.0001445128035469
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24159,341,0.80 [0.62-1.03],0.080143169457701
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24209,293,0.71 [0.54-0.93],0.0133475588995525
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24202,286,0.71 [0.54-0.94],0.01622772185714
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21664,87,0.51 [0.32-0.84],0.0071790402010937
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28054,77,0.81 [0.48-1.39],0.4477276114548747
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24477,659,0.87 [0.72-1.04],0.1297758995315591
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27152,163,1.04 [0.71-1.52],0.8432821252497552
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26720,2902,0.91 [0.83-0.99],0.0335432050994319
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23977,159,0.85 [0.59-1.24],0.4116631554594014
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24502,586,0.68 [0.56-0.82],6.627520453842177e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26314,274,0.90 [0.67-1.20],0.4778908521229635
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24201,285,0.64 [0.49-0.85],0.0015773611664504
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25727,1811,0.74 [0.66-0.83],9.149219387278413e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25147,1231,0.71 [0.62-0.81],3.47221103961518e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23884,66,0.73 [0.41-1.30],0.2866312962706864
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27219,230,0.75 [0.55-1.02],0.0697821302306779
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24026,208,0.83 [0.60-1.16],0.2818582787173372
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23948,130,0.91 [0.60-1.38],0.6464759884078339
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18994,56,0.56 [0.30-1.04],0.065713084524229
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26973,1289,0.78 [0.69-0.89],0.0002008344880405
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21017,104,1.09 [0.68-1.75],0.7185071996535043
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27363,112,0.88 [0.56-1.39],0.5923872087121964
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27911,241,0.88 [0.65-1.20],0.4267228855101221
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27698,28,0.79 [0.32-1.90],0.5924884479403012
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27209,1525,0.72 [0.64-0.81],9.568831059602904e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27900,81,0.92 [0.55-1.55],0.7549999193625005
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27862,247,0.85 [0.63-1.15],0.2832718042538846
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Cystitis,24767,258,0.74 [0.55-0.98],0.0389012752233046
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Dialysis,25738,54,0.71 [0.37-1.34],0.2856487213115399
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27594,343,0.87 [0.67-1.12],0.2690555602945766
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Endometriosis,21098,185,0.89 [0.63-1.27],0.5290283439480461
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21318,405,0.93 [0.73-1.18],0.5409842839288466
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21942,1029,0.77 [0.67-0.89],0.0004670821137404
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21855,5191,0.87 [0.82-0.93],5.540774757957545e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27884,65,0.75 [0.42-1.35],0.3423588690092736
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25558,218,0.69 [0.50-0.95],0.0225384444578595
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27514,406,0.80 [0.64-1.01],0.0655871520609704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Irregular menses,27599,131,0.70 [0.46-1.06],0.0962681885617272
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21224,311,1.12 [0.85-1.48],0.4036507016365583
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24589,80,0.79 [0.47-1.34],0.3832684732895247
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23419,2506,0.89 [0.81-0.98],0.0130508586762131
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21056,143,0.73 [0.49-1.08],0.1136935210465107
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28062,67,0.73 [0.41-1.29],0.2767111713073451
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28066,76,0.97 [0.57-1.68],0.9242198938168914
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26804,2295,0.81 [0.73-0.89],1.936646972475848e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24996,487,0.68 [0.55-0.84],0.0003196441074069
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27371,120,0.98 [0.63-1.51],0.910901354036165
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28012,397,0.81 [0.64-1.02],0.0716177403360457
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28014,93,0.73 [0.45-1.19],0.2121057499762218
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26478,1969,0.80 [0.72-0.88],2.278857784873247e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27317,209,0.84 [0.61-1.17],0.3022039222233793
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21071,158,0.62 [0.43-0.89],0.0096485343244381
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21290,377,1.24 [0.96-1.58],0.094109726136902
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,21024,111,0.91 [0.58-1.43],0.6954130666869198
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21124,211,0.89 [0.64-1.24],0.4897300868543819
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25611,271,0.82 [0.62-1.10],0.1837084238180541
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27743,128,0.68 [0.45-1.01],0.0582244021622523
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21227,314,1.04 [0.79-1.36],0.778039738788285
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21022,109,0.55 [0.36-0.85],0.0071249851176996
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21573,660,0.99 [0.82-1.19],0.9146894590092952
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,21077,164,0.98 [0.68-1.42],0.9240312811935568
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21520,607,1.07 [0.88-1.30],0.5070122298302158
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27857,38,0.89 [0.41-1.91],0.7651180805375105
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27875,2535,0.80 [0.73-0.88],4.722167029264644e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25509,169,1.03 [0.71-1.50],0.8649314703195307
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25788,104,0.65 [0.42-1.03],0.066185533023404
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27705,35,0.72 [0.33-1.58],0.4132660551024653
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24657,148,1.08 [0.73-1.61],0.6886593951497704
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27945,275,0.85 [0.64-1.13],0.2678410188973085
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21057,144,1.19 [0.80-1.77],0.4011805995847219
